These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19200835)

  • 1. New perspectives for hepatitis B vaccines and immunization.
    Rapicetta M; D'Ugo E; Argentini C; Catone S; Canitano A; Giuseppetti R; Gluck R
    Vaccine; 2009 May; 27(25-26):3271-5. PubMed ID: 19200835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck model.
    Roggendorf M; Schulte I; Xu Y; Lu M
    J Viral Hepat; 2007 Nov; 14 Suppl 1():51-7. PubMed ID: 17958643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity.
    Wang J; Gujar SA; Cova L; Michalak TI
    J Virol; 2007 Jan; 81(2):903-16. PubMed ID: 17079319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pre-S/S CHO-derived hepatitis B virus vaccine protects woodchucks from WHV productive infection.
    Argentini C; Giuseppetti R; D'Ugo E; La Sorsa V; Tritarelli E; Orobello S; Canitano A; Glück R; Rapicetta M
    Vaccine; 2005 May; 23(28):3649-56. PubMed ID: 15882525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The woodchuck: a model for therapeutic vaccination against hepadnaviral infection.
    Roggendorf M; Yang D; Lu M
    Pathol Biol (Paris); 2010 Aug; 58(4):308-14. PubMed ID: 20646874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen.
    Xing Y; Huang Z; Lin Y; Li J; Chou TH; Lu S; Wang S
    Vaccine; 2008 Sep; 26(40):5145-52. PubMed ID: 18462847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid emergence of a viral resistant mutant in WHV chronically infected woodchucks treated with lamivudine and a pre-S/S CHO-derived hepatitis B virus vaccine.
    D'Ugo E; Kondili LA; Canitano A; Catone S; Giuseppetti R; Gallinella B; Palmieri G; Orobello S; Argentini C; Glück R; Rapicetta M
    Vaccine; 2007 Jun; 25(26):4895-902. PubMed ID: 17531355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The woodchuck hepatitis B virus infection model for the evaluation of HBV therapies and vaccine therapies.
    D'Ugo E; Argentini C; Giuseppetti R; Canitano A; Catone S; Rapicetta M
    Expert Opin Drug Discov; 2010 Dec; 5(12):1153-62. PubMed ID: 22822718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity in mice and rabbits of DNA vaccines expressing woodchuck hepatitis virus antigens.
    Luxembourg A; Hannaman D; Wills K; Bernard R; Tennant BC; Menne S; Cote PJ
    Vaccine; 2008 Jul; 26(32):4025-33. PubMed ID: 18556096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of immune responses to an HBV DNA vaccine by electroporation.
    Luxembourg A; Hannaman D; Ellefsen B; Nakamura G; Bernard R
    Vaccine; 2006 May; 24(21):4490-3. PubMed ID: 16140436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the woodchuck model in the treatment of hepatitis B virus infection.
    Kulkarni K; Jacobson IM; Tennant BC
    Clin Liver Dis; 2007 Nov; 11(4):707-25, vii. PubMed ID: 17981226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
    Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
    Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of WHV-HDV replication in acute fatal course of woodchuck hepatitis.
    D'Ugo E; Canitano A; Catone S; Argentini C; Giuseppetti R; Orobello S; Palmieri G; Rapicetta M
    Arch Virol; 2008; 153(11):2069-76. PubMed ID: 18985276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release potency tests of hepatitis vaccines.
    Descamps J; Mary A; Rommel E; Anhoury ML; De Neys R; Duchêne M
    Dev Biol Stand; 1999; 101():289-94. PubMed ID: 10566803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).
    Knuf M; Szenborn L; Moro M; Petit C; Bermal N; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S97-S108. PubMed ID: 19325452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of interleukin 8 in woodchucks with chronic hepatitis B and hepatocellular carcinoma.
    Liu CJ; Huang YJ; Chen HL; Lin HT; Lin HL; Kuo ML; Huang JL; Chen DS; Chen PJ; Wu HL
    Genes Immun; 2009 Jan; 10(1):27-36. PubMed ID: 18971938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of neutralizing humoral response of DNA vaccine against duck hepatitis B virus envelope protein by co-delivery of cytokine genes.
    Saade F; Buronfosse T; Pradat P; Abdul F; Cova L
    Vaccine; 2008 Sep; 26(40):5159-64. PubMed ID: 18554756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vertical transmission of hepatitis B virus (HBV) from mothers negative for HBV surface antigen and positive for antibody to HBV core antigen.
    Walz A; Wirth S; Hucke J; Gerner P
    J Infect Dis; 2009 Oct; 200(8):1227-31. PubMed ID: 19751152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interferon-alpha gene family of Marmota himalayana, a Chinese marmot species with susceptibility to woodchuck hepatitis virus infection.
    Lu Y; Wang B; Huang H; Tian Y; Bao J; Dong J; Roggendorf M; Lu M; Yang D
    Dev Comp Immunol; 2008; 32(4):445-57. PubMed ID: 17936902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
    Wu JM; Huang YH; Lee PC; Lin HC; Lee SD
    J Clin Gastroenterol; 2009; 43(5):496-8. PubMed ID: 19247200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.